9/10/2021 12:38:17 PM -

Perched at its 52-week high, extended from any sound base. Disciplined investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Annual earnings (A criteria) history has been steady. Made a choppy ascent and the past 4 quarterly comparisons through Jun '21 showed very strong sales revenues and earnings increases above the +25% minimum (C criteria) of the fact-based investment system since last noted in the 3/11/20 mid-day report.



3/11/2020 12:35:56 PM -

Abruptly reversed after spiking to a new 52-week high, violating its 200 DMA line ($104) with today's 4th consecutive volume-driven loss. Prior mid-day reports cautioned members - "Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines."



3/10/2020 12:27:47 PM -

Abruptly reversed after spiking to a new 52-week high with today's 3rd consecutive volume-driven loss retesting support at its 200 DMA line ($104). Prior mid-day reports cautioned members - "Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines."



3/9/2020 12:31:59 PM -

Abruptly reversed after spiking to a new 52-week highs with volume-driven gains after testing support at its 200 DMA line. Prior mid-day reports cautioned members - "Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines."



3/6/2020 11:59:48 AM -

Abruptly reversed after spiking to a new 52-week highs with volume-driven gains after testing support at its 200 DMA line. Prior mid-day reports cautioned members - "Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines."



3/5/2020 12:21:16 PM -

Hitting new 52-week highs with a 2nd consecutive volume-driven gain after testing support at its 200 DMA line last week. Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines.



3/4/2020 11:02:55 AM -

Perched near its 52-week high after testing support at its 200 DMA line. Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines.



7/13/2012 12:28:49 PM -

Technically, it broke out to new 52-week and multi-year highs with a considerable volume-driven gain on the prior session. Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines.



7/9/2009 12:45:43 PM - Sales and earnings history show slow growth in recent quarters and years, with increases below the investment system guidelines. This company is also said to have been previously responsible for losing CANSLIM.net founder, Kenneth Gruneisen's blood, which caused undue delays and created a need for additional samples to be drawn. The tests at the time all worked out fine, as long as the "lost" blood is someplace safe...

9/1/2006 12:29:39 PM - "C" and sales history below guidelines and base is questionable.

7/25/2006 12:56:04 PM - Very good group. (ESRX, ACDO, WOOF, LABS) yet "C" (last reported only +6%) and sales history are below guidelines.

7/24/2006 12:43:49 PM - Very good group. (ESRX, ACDO, WOOF, LABS) yet "C" and sales history are below guidelines.

6/22/2005 12:31:50 PM - Very good group. (ESRX, ACDO, WOOF, LABS) "C" and sales history below guidelines.

5/2/2005 12:32:27 PM - Very good group. (ESRX, ACDO, WOOF, AMHC) "C" below guidelines.

4/29/2005 1:20:01 PM - Very good group. (ESRX, ACDO, WOOF, AMHC) Base somewhat questionable.